Correlation Between Eyebright Medical and Cabio Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyebright Medical and Cabio Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyebright Medical and Cabio Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyebright Medical Technology and Cabio Biotech Wuhan, you can compare the effects of market volatilities on Eyebright Medical and Cabio Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyebright Medical with a short position of Cabio Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyebright Medical and Cabio Biotech.

Diversification Opportunities for Eyebright Medical and Cabio Biotech

0.14
  Correlation Coefficient

Average diversification

The 3 months correlation between Eyebright and Cabio is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Eyebright Medical Technology and Cabio Biotech Wuhan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabio Biotech Wuhan and Eyebright Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyebright Medical Technology are associated (or correlated) with Cabio Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabio Biotech Wuhan has no effect on the direction of Eyebright Medical i.e., Eyebright Medical and Cabio Biotech go up and down completely randomly.

Pair Corralation between Eyebright Medical and Cabio Biotech

Assuming the 90 days trading horizon Eyebright Medical is expected to generate 4.14 times less return on investment than Cabio Biotech. In addition to that, Eyebright Medical is 1.2 times more volatile than Cabio Biotech Wuhan. It trades about 0.06 of its total potential returns per unit of risk. Cabio Biotech Wuhan is currently generating about 0.32 per unit of volatility. If you would invest  1,784  in Cabio Biotech Wuhan on November 4, 2024 and sell it today you would earn a total of  221.00  from holding Cabio Biotech Wuhan or generate 12.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Eyebright Medical Technology  vs.  Cabio Biotech Wuhan

 Performance 
       Timeline  
Eyebright Medical 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Eyebright Medical Technology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Eyebright Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Cabio Biotech Wuhan 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cabio Biotech Wuhan has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Cabio Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eyebright Medical and Cabio Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyebright Medical and Cabio Biotech

The main advantage of trading using opposite Eyebright Medical and Cabio Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyebright Medical position performs unexpectedly, Cabio Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabio Biotech will offset losses from the drop in Cabio Biotech's long position.
The idea behind Eyebright Medical Technology and Cabio Biotech Wuhan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity